Cochliodinol is an antibiotic metabolite of Chaetomium cochliodes and C. globosum. Shown to inhibit the metabolism and growth of a variety of bacterial genera. Also shown to inhibit some species from many genera of microfungi. Cochliodinol is the first reported asterriquinone structure isolated from Chaetomium species. Asterriquinone is an antitumor metabolite, and thus cochliodinol has been reported to exhibit antitumor activity.
1. Brewer, D., et al. 1970. Can. J. Microbiol. 16: 433-440. PMID: 4987295
2. Brewer, D., et al. 1984. Can. J. Microbiol. 30: 1068-1072. PMID: 6541963
3. Mocek, U., et al. 1996. J. Antibiot. 49: 854-859. PMID: 8931717
4. Kaji, A., et al. 1997. Anticancer Res. 17: 3675-3679. PMID: 9413222
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.